SUBSCRIBE
SUBSCRIBE

Elutia

NEWS
Dan Kitwood/Getty Images
FDA
Excessive Impurities Cause Recall of Pfizer’s Anti-Smoking Drug
Pfizer has voluntarily recalled two lots of Chantix 0.5 mg tablets, two lots of Chantix 1 mg tablets, and eight lots of a Chantix kit consisting of 0.5mg/1 mg tablets.
July 20, 2021
 · 
2 min read
 · 
Brandon May
Business
Aziyo Biologics Banks Some Cash And Former Osiris Exec As Its New CEO
June 15, 2017
 · 
1 min read
IN THE PRESS
Press Releases
Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™
March 28, 2025
 · 
5 min read
Press Releases
Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out
March 7, 2025
 · 
14 min read
Press Releases
Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025
February 21, 2025
 · 
1 min read
Press Releases
Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.
December 2, 2024
 · 
5 min read
Press Releases
Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025
November 15, 2024
 · 
14 min read
Press Releases
Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024
October 30, 2024
 · 
1 min read
Business
Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices
September 18, 2024
 · 
6 min read
News
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators
September 5, 2024
 · 
6 min read
Press Releases
Elutia to Participate in Upcoming Investor Conferences
September 4, 2024
 · 
1 min read
Press Releases
Elutia Announces Second Quarter 2024 Results
August 8, 2024
 · 
14 min read
Load More
JOBS